Ilesol Pharmaceuticals, a leading industrial-scale producer of full-spectrum CBD and non-detectable THC products, specializes in cosmetic ingredients, cosmetic products, and food supplements. Established in 2017 by a pair of experts in pharmaceutical process engineering, optimization, medicinal plant extraction, hemp processing, cultivation, and breeding, the company has quickly risen to prominence in the field.
Within its first year, Ilesol Pharmaceuticals provided hemp processing and extraction services, launching its inaugural products in early 2018. The company’s commitment to crafting tailor-made products for clients secured its position as the first European cannabinoid à la carte enterprise.
Primarily focusing on B2B wholesale and white/private label services, Ilesol Pharmaceuticals boasts a diverse array of CBD/CBG products, intermediates, cosmetic ingredients, food supplements, and cosmetic consumer goods. The company offers high purity isolated cannabinoids, THC-free products, and full-spectrum CBD products in various potencies.
In 2019, Ilesol Pharmaceuticals expanded its operations by acquiring a 3,400 m2 production facility in Varaždin, Croatia. Two years later, the company introduced its first CBD cosmetics line, Skin Greens — a product range designed to promote healthy and natural skin nutrition through the use of CBD and high-quality natural herbal active ingredients in functional cosmetic formulations.
By 2023, Ilesol Pharmaceuticals further broadened its product portfolio to include customized food supplements, botanical extracts, and functional mushrooms. As one of the premier cannabis manufacturers in the EU, Ilesol Pharmaceuticals takes pride in being among the few companies to manage in-house production from Croatian-sourced organic biomass to isolates and finished products.
The company’s robust Quality Management System adheres to globally recognized standards, such as ISO 22000 (Novel Food & Food Supplements), ISO 22716 (Cosmetic GMP), HACCP, and ISO 9001. Ilesol Pharmaceuticals’ commitment to these stringent standards cements its position at the pinnacle of EU CBD manufacturers.
Full Traceability and Guarantee of raw material origin
Knowledge of cutting-edge extraction and purification technologies
Production according to the highest industrial standards
Analytical support from 3rd party accredited laboratory with accredited analytical methods
Our products undergo rigorous quality control measures to ensure safety, stability, and efficacy.
Our products contain a full spectrum of naturally occurring cannabinoids and terpenes
We are a part of Novel Food Consortium, with applications in EU and UK.
When it comes to our business model, quality is our highest priority. Our mission is to ensure the highest level of quality and control at every stage of the production process. We are committed to full transparency and reliability in providing our partners with top-quality products.
Ilesol’s long-term goal is pharmaceutical production. The company has completed the project documentation for the production of Active Pharmaceutical Ingredients (APIs). With our extensive know-how and experience, we see the future of the company as becoming one of the cannabinoid giants in the pharmaceutical sector.
We are compliant with international food safety regulations, meeting the requirements of the United Nations’ Codex Alimentarius Commission (CAC) and the Health Products Regulatory Authority (HPRA). We have implemented the Hazard Analysis Critical Control Points (HACCP) management system; HRN EN ISO 22000:2018 Food Safety Management system. We hold cosmetic GMP ISO 22716 and ISO 9001 certificates. Our Quality Assurance (QA) and Quality Control (QC) processes assure vigorous implementation of certified Good Manufacturing Practices for food and cosmetic production. All of our products are third-party tested and free of pesticides, toxic solvent residues, and heavy metals. None of our products or ingredients have been tested on animals.